Cargando…

Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy

Tonsillectomy is a frequently performed surgical procedure in children, requiring post-operative analgesia. This study evaluated the efficacy and safety of nalbuphine or sufentanil combined with dexmedetomidine for patient-controlled intravenous analgesia (PCIA) after pediatric tonsillectomy adenoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Yingping, Zhou, Rui, Li, Zhengchen, Wang, Yuanyuan, Chen, Sandong, Zhao, Liyuan, Shao, Yi, Qi, Jinlian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117536/
https://www.ncbi.nlm.nih.gov/pubmed/35600878
http://dx.doi.org/10.3389/fphar.2022.908212
_version_ 1784710332103524352
author Jia, Yingping
Zhou, Rui
Li, Zhengchen
Wang, Yuanyuan
Chen, Sandong
Zhao, Liyuan
Shao, Yi
Qi, Jinlian
author_facet Jia, Yingping
Zhou, Rui
Li, Zhengchen
Wang, Yuanyuan
Chen, Sandong
Zhao, Liyuan
Shao, Yi
Qi, Jinlian
author_sort Jia, Yingping
collection PubMed
description Tonsillectomy is a frequently performed surgical procedure in children, requiring post-operative analgesia. This study evaluated the efficacy and safety of nalbuphine or sufentanil combined with dexmedetomidine for patient-controlled intravenous analgesia (PCIA) after pediatric tonsillectomy adenoidectomy. A total of 400 patients undergoing tonsillectomy with and without adenoidectomy were included in the study. Patients received a PCIA pump (0.5 mg/kg nalbuphine, 2 μg/kg dexmedetomidine and 0.9% sodium chloride to a total volume of 100 ml) for postoperative pain management were classified into Group ND (n = 200). Patients received a PCIA pump (2 μg/kg sufentanil, 2 μg/kg dexmedetomidine and 0.9% sodium chloride to a total volume of 100 ml) for postoperative pain management were classified into Group SD (n = 200). More stable hemodynamic changes were noted in Group ND than Group SD from 1 h to 48 h after operation. At 6, 12, 24, and 48 h after operation, the children in Group ND had higher Ramsay sedation scores than those in Group SD. The times to push the PCIA button in Group ND and Group SD were 2.44 ± 0.74 and 2.62 ± 1.00, showing significant differences (p = 0.041). The VASR scores of children in Group ND were significantly lower within 6, 12, and 24 h than those in Group SD (p < 0.05). The VASC scores of children in Group ND were significantly lower within four time points (2, 6, 12, and 24 h) than those in Group SD (p < 0.05). At 1st day after surgery, the children in Group ND had lower levels of serum ACTH, IL-6, and COR levels than those in Group SD (p < 0.001). The incidence rates of nausea and vomiting, and pruritus were significantly higher in Group SD than Group ND (5.00% vs. 11.00%, p = 0.028; 1.00% vs. 4.50%, p = 0.032). The total incidence rate of adverse reactions was significantly higher in Group SD than Group ND (15.00% vs. 31.00%, p = 0.0001). The study demonstrated that dexmedetomidine added to nalbuphine PCIA enhanced the analgesic effects, attenuated the postoperative pain, and reduced the stress response after pediatric tonsillectomy adenoidectomy.
format Online
Article
Text
id pubmed-9117536
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91175362022-05-20 Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy Jia, Yingping Zhou, Rui Li, Zhengchen Wang, Yuanyuan Chen, Sandong Zhao, Liyuan Shao, Yi Qi, Jinlian Front Pharmacol Pharmacology Tonsillectomy is a frequently performed surgical procedure in children, requiring post-operative analgesia. This study evaluated the efficacy and safety of nalbuphine or sufentanil combined with dexmedetomidine for patient-controlled intravenous analgesia (PCIA) after pediatric tonsillectomy adenoidectomy. A total of 400 patients undergoing tonsillectomy with and without adenoidectomy were included in the study. Patients received a PCIA pump (0.5 mg/kg nalbuphine, 2 μg/kg dexmedetomidine and 0.9% sodium chloride to a total volume of 100 ml) for postoperative pain management were classified into Group ND (n = 200). Patients received a PCIA pump (2 μg/kg sufentanil, 2 μg/kg dexmedetomidine and 0.9% sodium chloride to a total volume of 100 ml) for postoperative pain management were classified into Group SD (n = 200). More stable hemodynamic changes were noted in Group ND than Group SD from 1 h to 48 h after operation. At 6, 12, 24, and 48 h after operation, the children in Group ND had higher Ramsay sedation scores than those in Group SD. The times to push the PCIA button in Group ND and Group SD were 2.44 ± 0.74 and 2.62 ± 1.00, showing significant differences (p = 0.041). The VASR scores of children in Group ND were significantly lower within 6, 12, and 24 h than those in Group SD (p < 0.05). The VASC scores of children in Group ND were significantly lower within four time points (2, 6, 12, and 24 h) than those in Group SD (p < 0.05). At 1st day after surgery, the children in Group ND had lower levels of serum ACTH, IL-6, and COR levels than those in Group SD (p < 0.001). The incidence rates of nausea and vomiting, and pruritus were significantly higher in Group SD than Group ND (5.00% vs. 11.00%, p = 0.028; 1.00% vs. 4.50%, p = 0.032). The total incidence rate of adverse reactions was significantly higher in Group SD than Group ND (15.00% vs. 31.00%, p = 0.0001). The study demonstrated that dexmedetomidine added to nalbuphine PCIA enhanced the analgesic effects, attenuated the postoperative pain, and reduced the stress response after pediatric tonsillectomy adenoidectomy. Frontiers Media S.A. 2022-05-05 /pmc/articles/PMC9117536/ /pubmed/35600878 http://dx.doi.org/10.3389/fphar.2022.908212 Text en Copyright © 2022 Jia, Zhou, Li, Wang, Chen, Zhao, Shao and Qi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Jia, Yingping
Zhou, Rui
Li, Zhengchen
Wang, Yuanyuan
Chen, Sandong
Zhao, Liyuan
Shao, Yi
Qi, Jinlian
Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
title Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
title_full Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
title_fullStr Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
title_full_unstemmed Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
title_short Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy
title_sort analgesic effects and safety of dexmedetomidine added to nalbuphine or sufentanil patient-controlled intravenous analgesia for children after tonsillectomy adenoidectomy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117536/
https://www.ncbi.nlm.nih.gov/pubmed/35600878
http://dx.doi.org/10.3389/fphar.2022.908212
work_keys_str_mv AT jiayingping analgesiceffectsandsafetyofdexmedetomidineaddedtonalbuphineorsufentanilpatientcontrolledintravenousanalgesiaforchildrenaftertonsillectomyadenoidectomy
AT zhourui analgesiceffectsandsafetyofdexmedetomidineaddedtonalbuphineorsufentanilpatientcontrolledintravenousanalgesiaforchildrenaftertonsillectomyadenoidectomy
AT lizhengchen analgesiceffectsandsafetyofdexmedetomidineaddedtonalbuphineorsufentanilpatientcontrolledintravenousanalgesiaforchildrenaftertonsillectomyadenoidectomy
AT wangyuanyuan analgesiceffectsandsafetyofdexmedetomidineaddedtonalbuphineorsufentanilpatientcontrolledintravenousanalgesiaforchildrenaftertonsillectomyadenoidectomy
AT chensandong analgesiceffectsandsafetyofdexmedetomidineaddedtonalbuphineorsufentanilpatientcontrolledintravenousanalgesiaforchildrenaftertonsillectomyadenoidectomy
AT zhaoliyuan analgesiceffectsandsafetyofdexmedetomidineaddedtonalbuphineorsufentanilpatientcontrolledintravenousanalgesiaforchildrenaftertonsillectomyadenoidectomy
AT shaoyi analgesiceffectsandsafetyofdexmedetomidineaddedtonalbuphineorsufentanilpatientcontrolledintravenousanalgesiaforchildrenaftertonsillectomyadenoidectomy
AT qijinlian analgesiceffectsandsafetyofdexmedetomidineaddedtonalbuphineorsufentanilpatientcontrolledintravenousanalgesiaforchildrenaftertonsillectomyadenoidectomy